Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Introduction to antibody engineering and phage display.

N A Watkins1, W H Ouwehand

  • 1Division of Transfusion Medicine, Department of Haematology, University of Cambridge, Cambridge, UK. naw23@cam.ac.uk

Vox Sanguinis
|April 15, 2000
PubMed
Summary

Murine monoclonal antibodies (mAbs) are vital for diagnostics and therapeutics but can cause immune responses. Antibody engineering and phage display techniques are now used to create human mAbs, improving their therapeutic compatibility.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

NOX1 loss-of-function genetic variants in patients with inflammatory bowel disease.

Mucosal immunology·2017
Same author

Platelet responses to agonists in a cohort of highly characterised platelet donors are consistent over time.

Vox sanguinis·2016
Same author

Who should donate blood? Policy decisions on donor deferral criteria should protect recipients and be fair to donors.

Transfusion medicine (Oxford, England)·2015
Same author

Sensitivity of assays for the detection of HPA-1a antibodies: results of an international workshop demonstrating the impact of cation chelation from integrin αIIbβ3 on three widely used assays.

Vox sanguinis·2013
Same author

Reactome - a curated knowledgebase of biological pathways: megakaryocytes and platelets.

Journal of thrombosis and haemostasis : JTH·2012
Same author

Inhibition of MT1-MMP activity using functional antibody fragments selected against its hemopexin domain.

The international journal of biochemistry & cell biology·2011

Area of Science:

  • Immunology
  • Biotechnology

Background:

  • Vertebrate immune systems produce specific antibodies.
  • Murine monoclonal antibodies (mAbs) are crucial in diagnostics and therapeutics.
  • Murine mAbs can elicit immunogenic responses in humans.

Purpose of the Study:

  • To introduce antibody engineering and phage display techniques.
  • To discuss the development of antibody fragments as diagnostic and therapeutic reagents.
  • To address the immunogenicity challenges of murine mAbs.

Main Methods:

  • Review of antibody engineering strategies.
  • Overview of antibody phage display technology.
  • Discussion of antibody fragment development.

Main Results:

Related Experiment Videos

  • Antibody engineering techniques minimize immunogenicity of murine mAbs.
  • Phage display enables production of human mAbs.
  • Antibody fragments are viable diagnostic and therapeutic agents.

Conclusions:

  • Antibody engineering and phage display are key to overcoming murine mAb immunogenicity.
  • Human mAbs and antibody fragments offer improved therapeutic potential.
  • These advancements are critical for developing next-generation diagnostics and therapeutics.